 |
 |
 |
|
 |
|
 |
|
 |
Scientific Advisory Board
Stephen J. Benkovic, Ph.D., is Evan Pugh Professor holder of the Eberly Chair in Chemistry at Penn State University. His work has been recognized by awards and fellowships including: Alfred P. Sloan Fellowship, NIH Career Development Award, Guggenheim Fellowship, the Pfizer Award in Enzyme Chemistry, the Gowland Hopkins Award, the Repligen Award for Chemistry of Biological Processes, the Alfred Bader Award, the Chemical Pioneer Award from the American Institute of Chemists, the Christian B. Afinsen Award, and the Benjamin Franklin Medal in Life Sciences. He has been elected to memberships in the American Academy of Arts and Sciences, the National Academy of Sciences, the Institute of Medicine, National Academy of Sciences, and the American Philosophical Society. Dr. Benkovic has advised life science venture funds and served as Chair of the Scientific Advisory Board at GSK. Dr. Benkovic received his B.S. degree in Chemistry and A.B. degree in English Literature from Lehigh University, the Ph.D. in Organic Chemistry from Cornell University, and was a postdoctoral research associate at the University of California, Santa Barbara. Marvin Miller, Ph.D., a member of Azevan's Scientific Advisory Board, is the George and Winifred Clark Chair Professor of Chemistry and Biochemistry at the University of Notre Dame. His research group is internationally recognized for its expertise in synthetic organic, bioorganic and medicinal chemistry. Dr. Miller has published extensively, his group has several patents, and he has presented over 150 invited lectures worldwide. His research has been fully funded for over 20 years by the NIH, private foundations and industry. Prof. Miller was a Fellow of the Alfred P. Sloan Foundation (1981-1985) and received an NIH Career Development Award (1983-1988). He has served on the editorial advisory board of several major journals, on NIH study sections, and review panels for several other funding agencies. Prof. Miller has been a consultant for several pharmaceutical and biotech companies. He is a member of the scientific advisory boards for NewBiotics and North Dakota Sate Univesity Center for Protease Research (NIH COBRA Center). He received his bachelor's degree in chemistry from North Dakota State University, a Ph.D. from Cornell University and was an NIH postdoctoral fellow at the University of California at Berkeley.  Meir Steiner, M.D., Ph.D. FRCPC joined the Dept. of Psychiatry at McMaster University in 1981. He has served as head of the Clinical Studies Program, Chief and Clinical Director of the department, and Director of Research. Since 1988, he has been Director of the Women's Health Concerns Clinic. In addition to his current positions as Professor of Psychiatry and Behavioural Neurosciences, Dr. Steiner holds additional appointments at the University of Toronto.
Professor Steiner's primary areas of research and publications have been the pathophysiology and psychopathology of mood disorders related to women's reproductive cyclicity. Since 1970, he has more than 600 publications, abstracts, preliminary communications and panel discussions in the field. He serves on the editorial or advisory boards of several professional journals and has co-authored and edited several books related to mood disorders in women. Professor Steiner is a member of many professional societies, and in 2000 the CCNP awarded him the Heinz Lehman Award for outstanding contributions in neuropsychopharmacology.. Professor Steiner is the Past President and the current Development Officer of the North American Society for Psychosocial Obstetrics and Gynecology. He serves on the Executive Board of The Marce Society and on the Isis Network on "Sex, Gender, Drugs and the Brain" for the Society of Women's Health Research. Professor Steiner graduated magna cum laude receiving his MD from the Tel Aviv University in 1968 and his PhD in Neurosciences in 1979 from the University of Michigan, Ann Arbor. |
Michael Brownstein, Ph.D., M.D., Scientific Advisory Board Chair, earned his bachelor's degree from Columbia University and completed his graduate training at the University of Chicago, where he earned an M.D. and Ph.D. in pharmacology. He received his clinical training at the Boston Children's Hospital and then moved to the National Institutes of Health to work with Julius Axelrod, recipient of a Nobel Prize in 1970 for his studies in the field of neuropharmacology. Dr. Brownstein remained at NIH after completing his fellowship, where he served as Chief of the Laboratory of Genetics of the National Institute of Mental Health and the National Human Genome Research Institute. For two years, he was the Scientific Director of the NIMH Intramural Research Program. While at the NIMH/NHGRI, he directed the Brain Molecular Anatomy Project. Simultaneously, he contributed to the Mammalian Gene Collection, a trans-Institutional effort to clone and sequence cDNAs corresponding to all human, mouse, and rat transcripts. Subsequently he directed the functional genomics program at the J. Craig Venter Institute in Rockville, MD for three years. Currently he is a Scientist Emeritus at the NIH. He has worked in the fields of neurobiology, neuroendocrinology, biochemical pharmacology, genetics, and genomics; has published more than 300 papers in peer reviewed journals; and has served on major editorial boards and continues to serve on a number of scientific advisory boards. Dr. Brownstein also co-founded several successful bio-pharmaceutical companies.